| Identification | Back Directory | [Name]
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate | [CAS]
1050477-43-4 | [Synonyms]
2-cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-1,6-naphthyridine-3-carboxylate
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-, 2-cyanoethyl ester
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-1,4,5,6-tetrahydro-2,8-dimethyl-5-oxo-, 2-cyanoethyl ester (ACI) | [EINECS(EC#)]
810-149-0 | [Molecular Formula]
C22H20N4O4 | [MOL File]
1050477-43-4.mol | [Molecular Weight]
404.42 |
| Chemical Properties | Back Directory | [vapor pressure ]
0.006Pa at 25℃ | [Water Solubility ]
6.2mg/L at 20℃ | [InChI]
InChI=1S/C22H20N4O4/c1-12-11-25-21(27)19-18(15-6-5-14(10-24)9-16(15)29-3)17(13(2)26-20(12)19)22(28)30-8-4-7-23/h5-6,9,11,18,26H,4,8H2,1-3H3,(H,25,27) | [InChIKey]
YUBVPYQJGHKIIA-UHFFFAOYSA-N | [SMILES]
N1C2=C(C(=O)NC=C2C)C(C2=CC=C(C#N)C=C2OC)C(C(OCCC#N)=O)=C1C | [LogP]
0.97 |
| Hazard Information | Back Directory | [Uses]
2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxylate is a pharmaceutical intermediary ingredient used in the preparation of Finerenone. Finerenone is a non-steroidal, selective salicorticosteroid receptor (MR) antagonist that is used to reduce the risk of serious renal and cardiac problems (e.g., decreased kidney function, end-stage renal disease, cardiovascular death, heart attack, and hospitalisation for heart failure) in patients with chronic kidney disease associated with type 2 diabetes mellitus. | [Flammability and Explosibility]
Notclassified |
|
|